Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for O96004

Entry ID Method Resolution Chain Position Source
AF-O96004-F1 Predicted AlphaFoldDB

202 variants for O96004

Variant ID(s) Position Change Description Diseaes Association Provenance
rs564241048
RCV002546807
CA3526639
COSM1064729
RCV001337137
41 Y>C Hypoplastic left heart syndrome Variant assessed as Somatic; 0.0 impact. endometrium Inborn genetic diseases [ClinVar, NCI-TCGA, Cosmic] Yes ClinGen
cosmic curated
ClinVar
1000Genomes
ExAC
NCI-TCGA
TOPMed
dbSNP
gnomAD
CA3526611
RCV000813025
rs772843786
63 P>S Hypoplastic left heart syndrome [ClinVar] Yes ClinGen
ClinVar
ExAC
dbSNP
gnomAD
CA3526602
rs764242373
RCV001318486
72 Y>C Hypoplastic left heart syndrome [ClinVar] Yes ClinGen
ClinVar
ExAC
dbSNP
gnomAD
rs201302313
RCV001701712
CA3526593
RCV000473290
RCV000238645
83 G>W Hypoplastic left heart syndrome [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
RCV000633472
CA361922968
rs1177737621
86 E>V Hypoplastic left heart syndrome [ClinVar] Yes ClinGen
ClinVar
TOPMed
dbSNP
CA10582411
RCV000232915
RCV001317302
rs878854746
97 G>C Hypoplastic left heart syndrome Hypoplastic left heart syndrome 1 [ClinVar] Yes ClinGen
ClinVar
Ensembl
dbSNP
RCV001295749
CA3526568
rs745686103
124 V>L Hypoplastic left heart syndrome [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
rs1246794989
CA361920650
RCV001323212
184 H>L Hypoplastic left heart syndrome [ClinVar] Yes ClinGen
ClinVar
dbSNP
gnomAD
RCV000227604
CA10582410
RCV001343245
rs878854747
196 K>R Hypoplastic left heart syndrome Hypoplastic left heart syndrome 1 [ClinVar] Yes ClinGen
ClinVar
Ensembl
dbSNP
CA361924789
rs1354473345
2 N>D No ClinGen
TOPMed
gnomAD
CA361924777
rs1299508908
3 L>I No ClinGen
TOPMed
rs1299508908
CA361924776
3 L>V No ClinGen
TOPMed
CA3526660
rs767528053
4 V>M No ClinGen
ExAC
gnomAD
TCGA novel 5 G>A Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA361924217
rs1460357937
5 G>D No ClinGen
gnomAD
rs1397025136
CA361924223
5 G>R No ClinGen
TOPMed
CA3526659
rs762997931
6 S>R No ClinGen
ExAC
gnomAD
CA3526658
rs371033200
8 A>S Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
CA130060251
rs371033200
8 A>T No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA361924143
rs1478174885
9 H>Y No ClinGen
gnomAD
rs570134327
CA130060233
12 H>Y No ClinGen
1000Genomes
gnomAD
rs1054562820
CA130060223
13 H>L No ClinGen
TOPMed
gnomAD
rs769999347
CA3526657
13 H>Y No ClinGen
ExAC
TOPMed
gnomAD
rs1316132356
CA361924019
14 H>R No ClinGen
TOPMed
rs200556971
CA3526656
16 P>T No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA3526653
rs768925214
17 H>Y No ClinGen
ExAC
gnomAD
TCGA novel 18 P>H Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1333509227
CA361923939
18 P>T No ClinGen
gnomAD
rs747513609
CA3526652
19 A>G No ClinGen
ExAC
gnomAD
rs1355879284
CA361923905
20 H>Q No ClinGen
gnomAD
CA361923897
COSM4155572
rs780396101
21 P>L kidney [Cosmic] No ClinGen
cosmic curated
ExAC
TOPMed
gnomAD
CA3526651
rs780396101
21 P>R No ClinGen
ExAC
TOPMed
gnomAD
CA361923890
rs1270137702
22 M>V No ClinGen
TOPMed
CA361923872
rs1389429025
23 L>V No ClinGen
gnomAD
CA3526650
rs772757234
24 H>R No ClinGen
ExAC
TOPMed
gnomAD
CA361923859
rs1398607391
24 H>Y No ClinGen
gnomAD
rs745362462
CA3526649
25 E>K No ClinGen
ExAC
gnomAD
rs1261908051
CA361923828
26 P>L No ClinGen
TOPMed
CA3526648
rs528298246
26 P>S No ClinGen
1000Genomes
ExAC
gnomAD
CA3526647
rs756908501
29 F>L No ClinGen
ExAC
gnomAD
CA361923774
rs753450334
30 G>R No ClinGen
ExAC
TOPMed
gnomAD
CA3526646
rs753450334
30 G>S No ClinGen
ExAC
TOPMed
gnomAD
rs777581629
CA3526645
31 P>Q No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 31 P>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA361923688
rs1253357213
34 R>L No ClinGen
gnomAD
CA361923652
rs1199817968
36 H>R No ClinGen
gnomAD
CA3526641
rs759535790
37 Q>H No ClinGen
ExAC
TOPMed
CA3526642
rs533319519
37 Q>R No ClinGen
1000Genomes
ExAC
gnomAD
rs564241048
CA3526640
41 Y>S No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA3526637
rs776751181
42 F>L No ClinGen
ExAC
gnomAD
CA3526638
rs762046238
42 F>L No ClinGen
ExAC
gnomAD
CA3526636
rs768965463
43 Q>R No ClinGen
ExAC
TOPMed
gnomAD
CA3526635
rs145232171
44 S>R No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA361923506
rs1297503043
44 S>T No ClinGen
TOPMed
CA3526633
rs772706064
45 W>C No ClinGen
ExAC
TOPMed
gnomAD
rs1296594232
CA361923496
45 W>G No ClinGen
TOPMed
CA130060170
rs141689288
45 W>S No ClinGen
ESP
TOPMed
gnomAD
rs746385291
CA3526632
46 L>M No ClinGen
ExAC
gnomAD
rs778513187
CA3526631
48 S>G No ClinGen
ExAC
gnomAD
rs770592263
CA361923432
CA3526630
48 S>R No ClinGen
ExAC
TOPMed
gnomAD
CA3526629
rs748866943
49 P>R No ClinGen
ExAC
TOPMed
gnomAD
CA361923425
rs1463053457
49 P>S No ClinGen
gnomAD
CA361923417
rs1468987419
50 A>P No ClinGen
gnomAD
CA361923415
rs1468987419
50 A>T No ClinGen
gnomAD
CA361923396
rs1365842411
51 D>V No ClinGen
TOPMed
gnomAD
rs777266765
CA3526628
52 A>T No ClinGen
ExAC
gnomAD
CA361923384
rs1454187248
53 A>T No ClinGen
gnomAD
rs1251644234
CA361923375
53 A>V No ClinGen
TOPMed
gnomAD
rs780969396
CA3526626
54 P>L No ClinGen
ExAC
gnomAD
CA3526625
rs780969396
54 P>R No ClinGen
ExAC
gnomAD
rs1202928556
CA361923330
56 F>L No ClinGen
gnomAD
CA361923319
rs1346301899
57 P>L No ClinGen
gnomAD
rs201496181
CA3526623
58 A>E No ClinGen
ExAC
TOPMed
gnomAD
CA361923305
rs201496181
58 A>G No ClinGen
ExAC
TOPMed
gnomAD
CA361923307
rs1352583664
58 A>S No ClinGen
gnomAD
TCGA novel 58 A>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA3526620
rs754000582
59 G>S No ClinGen
ExAC
CA3526618
rs761028320
60 G>E No ClinGen
ExAC
gnomAD
CA3526619
rs202045612
60 G>R No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs760076464
CA3526615
61 P>L No ClinGen
ExAC
TOPMed
gnomAD
rs760076464
CA361923263
61 P>Q No ClinGen
ExAC
TOPMed
gnomAD
CA3526616
rs768012504
61 P>S No ClinGen
ExAC
gnomAD
rs768012504
CA361923276
61 P>T No ClinGen
ExAC
gnomAD
CA3526610
rs769262740
63 P>L No ClinGen
ExAC
gnomAD
rs1196044769
CA361923222
64 A>S No ClinGen
gnomAD
rs1478071174
CA361923209
65 A>G No ClinGen
gnomAD
CA361923201
rs1190602578
COSM590810
66 A>S lung [Cosmic] No ClinGen
cosmic curated
gnomAD
rs1190602578
CA361923204
66 A>T No ClinGen
gnomAD
rs780916501
CA3526608
67 A>V No ClinGen
ExAC
gnomAD
rs374965548
CA3526607
68 A>P No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs1219669852
CA361923163
69 A>D No ClinGen
gnomAD
rs1282472466
CA361923170
69 A>S No ClinGen
gnomAD
rs1282472466
CA361923173
69 A>T No ClinGen
gnomAD
CA130060067
rs576059307
70 T>P No ClinGen
1000Genomes
CA3526605
rs758422053
71 A>S No ClinGen
ExAC
TOPMed
gnomAD
CA3526604
rs758422053
71 A>T No ClinGen
ExAC
TOPMed
gnomAD
rs1217088770
CA361923121
73 G>D No ClinGen
TOPMed
CA3526601
rs756237060
73 G>S No ClinGen
ExAC
gnomAD
CA3526600
rs752995620
CA361923091
75 D>E No ClinGen
ExAC
gnomAD
rs767888040
CA3526599
76 A>T No ClinGen
ExAC
gnomAD
rs1373952727
CA361923066
77 R>S No ClinGen
gnomAD
rs1176090594
CA361923053
CA361923054
79 G>R No ClinGen
TOPMed
gnomAD
rs774910795
CA3526597
80 Q>H No ClinGen
ExAC
gnomAD
rs201037401
CA3526598
80 Q>R No ClinGen
1000Genomes
ExAC
CA3526596
rs766789740
81 S>C No ClinGen
ExAC
gnomAD
rs763518945
CA3526595
81 S>T No ClinGen
ExAC
gnomAD
rs772538065
CA3526594
82 P>L No ClinGen
ExAC
TOPMed
gnomAD
CA361922988
rs1167066563
84 R>W No ClinGen
gnomAD
CA3526587
rs369296058
91 R>G No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs1320086824
CA361922905
91 R>L No ClinGen
gnomAD
CA361922913
rs369296058
91 R>S No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs1353975436
CA361922877
94 R>Q Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs777670897
CA3526585
94 R>W No ClinGen
ExAC
gnomAD
rs752869371
CA3526583
95 R>Q No ClinGen
ExAC
TOPMed
gnomAD
CA3526584
rs756183625
95 R>W No ClinGen
ExAC
gnomAD
CA3526582
rs572764589
96 K>E No ClinGen
1000Genomes
ExAC
gnomAD
TCGA novel 99 G>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs751904421
CA3526579
99 G>A No ClinGen
ExAC
gnomAD
rs751904421
CA3526580
99 G>V No ClinGen
ExAC
gnomAD
rs763319157
CA3526577
102 K>E No ClinGen
ExAC
gnomAD
TCGA novel
CA361922758
rs1419800202
102 K>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
ClinGen
gnomAD
rs758433854
CA130059914
103 E>D No ClinGen
Ensembl
CA361922748
rs1182283102
103 E>G No ClinGen
TOPMed
gnomAD
CA130059896
rs765342459
105 R>I No ClinGen
Ensembl
CA361922690
rs1206454242
107 T>A No ClinGen
TOPMed
gnomAD
CA361922691
rs1206454242
107 T>P No ClinGen
TOPMed
gnomAD
CA130059884
rs905545828
110 I>L No ClinGen
TOPMed
rs761291470
CA3526574
112 S>C No ClinGen
ExAC
gnomAD
rs776179261
CA3526573
112 S>R No ClinGen
ExAC
TOPMed
gnomAD
rs774267927
CA130059867
114 F>L No ClinGen
gnomAD
rs536000696
CA3526571
117 L>F No ClinGen
1000Genomes
ExAC
gnomAD
rs1449580591
CA361922498
118 R>L No ClinGen
gnomAD
CA361922493
rs1400422414
119 E>* No ClinGen
TOPMed
gnomAD
rs775093878
CA3526570
119 E>D No ClinGen
ExAC
TOPMed
gnomAD
CA361922496
rs1400422414
119 E>Q No ClinGen
TOPMed
gnomAD
CA130059851
rs1048063616
122 P>R No ClinGen
TOPMed
rs1481488405
CA361922442
122 P>S No ClinGen
TOPMed
CA361922418
rs1165033501
COSM385961
123 N>K lung [Cosmic] No ClinGen
cosmic curated
TOPMed
gnomAD
CA130059848
rs745686103
124 V>M No ClinGen
ExAC
TOPMed
gnomAD
CA361922393
rs1405443403
125 P>L No ClinGen
gnomAD
rs1440191810
CA361922372
127 D>Y No ClinGen
gnomAD
TCGA novel 129 K>missing Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA361922272
rs1467186459
133 I>L No ClinGen
gnomAD
CA130059828
rs974646425
134 K>* No ClinGen
TOPMed
gnomAD
CA361922254
rs1222504650
134 K>R No ClinGen
gnomAD
rs765936211 136 L>A Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No NCI-TCGA
COSM281622
rs374536409
CA3526564
137 R>H Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
CA3526563
rs374536409
137 R>L No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs771047758
CA3526565
137 R>S No ClinGen
ExAC
gnomAD
CA3526562
rs755192128
140 T>A No ClinGen
ExAC
gnomAD
rs1378346540
CA361922173
140 T>N No ClinGen
gnomAD
CA361922163
rs1303293556
141 S>N No ClinGen
gnomAD
CA3526560
rs140560109
144 A>S No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs140560109
CA3526561
144 A>T No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1052192853
CA130059781
145 Y>C No ClinGen
Ensembl
CA361922023
rs1452539216
148 D>E No ClinGen
gnomAD
CA3526558
rs750803617
148 D>G No ClinGen
ExAC
gnomAD
CA361922013
rs1270361699
149 V>L No ClinGen
TOPMed
rs762375465
CA3526556
152 K>E No ClinGen
ExAC
TOPMed
gnomAD
CA361921864
rs1582056958
156 S>F No ClinGen
Ensembl
CA361921780
rs1191667279
159 P>L No ClinGen
gnomAD
rs1561711379
CA361921790
159 P>T No ClinGen
Ensembl
CA130059728
rs987403652
160 E>G No ClinGen
TOPMed
gnomAD
CA361921751
rs1269484400
161 A>V No ClinGen
gnomAD
rs1192017843
CA361921738
162 F>L No ClinGen
gnomAD
CA361921724
rs1269763181
163 K>Q No ClinGen
TOPMed
rs202139442
CA3526552
167 K>M No ClinGen
ExAC
TOPMed
gnomAD
rs1240546642
CA361921651
167 K>Q No ClinGen
gnomAD
CA3526551
rs202139442
COSM1496075
167 K>R kidney [Cosmic] No ClinGen
cosmic curated
ExAC
TOPMed
gnomAD
CA361921628
rs1327129838
168 K>* No ClinGen
gnomAD
rs201984942
CA3526548
171 G>D No ClinGen
1000Genomes
ExAC
CA361921540
rs1166385384
172 G>C No ClinGen
TOPMed
COSM290318
CA361921530
rs1313460396
173 R>C Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
NCI-TCGA
TOPMed
gnomAD
CA130059698
rs146912397
173 R>H No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs146912397
CA3526547
173 R>L No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1313460396
CA361921534
173 R>S No ClinGen
TOPMed
gnomAD
CA3526546
rs781370812
174 E>G No ClinGen
ExAC
gnomAD
rs1164568199
CA361921513
COSM1064724
175 S>N Variant assessed as Somatic; impact. endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
NCI-TCGA
TOPMed
rs747099689
CA130059683
177 R>L No ClinGen
ExAC
CA3526544
rs747099689
177 R>Q No ClinGen
ExAC
CA361921456
rs768888751
177 R>W No ClinGen
ExAC
gnomAD
rs1333755459
CA361920671
182 Q>K No ClinGen
gnomAD
rs1340776953
CA361920635
186 G>D No ClinGen
gnomAD
CA130058458
rs929460819
188 P>A No ClinGen
TOPMed
rs147677474
CA3526519
189 P>L No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs1389554299
CA361920618
189 P>S No ClinGen
gnomAD
rs778198835
CA3526518
190 A>S No ClinGen
ExAC
gnomAD
CA3526517
rs756586663
190 A>V No ClinGen
ExAC
gnomAD
CA3526515
rs373277337
194 V>A No ClinGen
ESP
ExAC
TOPMed
TCGA novel 195 E>K Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA130058409
rs762914657
195 E>Q No ClinGen
gnomAD
rs754637839
CA3526513
199 K>Q No ClinGen
ExAC
gnomAD
CA3526512
rs751211164
200 G>E No ClinGen
ExAC
gnomAD
CA3526511
rs766161267
202 T>S No ClinGen
ExAC
gnomAD
rs762786810
CA3526510
203 G>A No ClinGen
ExAC
gnomAD
CA3526508
rs765198552
205 P>Q No ClinGen
ExAC
gnomAD
CA361920524
rs1439266037
205 P>T No ClinGen
TOPMed
gnomAD
rs772091154
CA3526505
208 V>L No ClinGen
ExAC
gnomAD
CA3526504
rs746068193
210 A>E No ClinGen
ExAC
gnomAD
CA361920485
rs746068193
210 A>V Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA3526502
rs771160670
215 Q>* No ClinGen
ExAC
gnomAD
rs985784176
CA130058340
215 Q>R No ClinGen
TOPMed

No associated diseases with O96004

1 regional properties for O96004

Type Name Position InterPro Accession
domain Myc-type, basic helix-loop-helix (bHLH) domain 94 - 152 IPR011598

Functions

Description
EC Number
Subcellular Localization
  • Nucleus, nucleoplasm
  • Nucleus, nucleolus
  • Interaction with MDFIC sequesters it into the nucleolus, preventing the transcription factor activity
  • Phosphorylation by PLK4 disrupts the interaction with MDFIC and releases it from the nucleolus, leading to transcription factor activity (By similarity)
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

6 GO annotations of cellular component

Name Definition
chromatin The ordered and organized complex of DNA, protein, and sometimes RNA, that forms the chromosome.
cytoplasm The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
nucleolus A small, dense body one or more of which are present in the nucleus of eukaryotic cells. It is rich in RNA and protein, is not bounded by a limiting membrane, and is not seen during mitosis. Its prime function is the transcription of the nucleolar DNA into 45S ribosomal-precursor RNA, the processing of this RNA into 5.8S, 18S, and 28S components of ribosomal RNA, and the association of these components with 5S RNA and proteins synthesized outside the nucleolus. This association results in the formation of ribonucleoprotein precursors; these pass into the cytoplasm and mature into the 40S and 60S subunits of the ribosome.
nucleoplasm That part of the nuclear content other than the chromosomes or the nucleolus.
nucleus A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
RNA polymerase II transcription regulator complex A transcription factor complex that acts at a regulatory region of a gene transcribed by RNA polymerase II.

11 GO annotations of molecular function

Name Definition
bHLH transcription factor binding Binding to a basic Helix-Loop-Helix (bHLH) superfamily of transcription factors, important regulatory components in transcriptional networks of many developmental pathways.
DNA-binding transcription activator activity, RNA polymerase II-specific A DNA-binding transcription factor activity that activates or increases transcription of specific gene sets transcribed by RNA polymerase II.
DNA-binding transcription factor activity, RNA polymerase II-specific A DNA-binding transcription factor activity that modulates the transcription of specific gene sets transcribed by RNA polymerase II.
DNA-binding transcription repressor activity, RNA polymerase II-specific A DNA-binding transcription factor activity that represses or decreases the transcription of specific gene sets transcribed by RNA polymerase II.
enzyme binding Binding to an enzyme, a protein with catalytic activity.
identical protein binding Binding to an identical protein or proteins.
protein homodimerization activity Binding to an identical protein to form a homodimer.
RNA polymerase II cis-regulatory region sequence-specific DNA binding Binding to a specific upstream regulatory DNA sequence (transcription factor recognition sequence or binding site) located in cis relative to the transcription start site (i.e., on the same strand of DNA) of a gene transcribed by RNA polymerase II.
RNA polymerase II transcription regulatory region sequence-specific DNA binding Binding to a specific sequence of DNA that is part of a regulatory region that controls the transcription of a gene or cistron by RNA polymerase II.
RNA polymerase II-specific DNA-binding transcription factor binding Binding to a sequence-specific DNA binding RNA polymerase II transcription factor, any of the factors that interact selectively and non-covalently with a specific DNA sequence in order to modulate transcription.
transcription coregulator binding Binding to a transcription coregulator, a protein involved in regulation of transcription via protein-protein interactions with transcription factors and other transcription regulatory proteins. Cofactors do not bind DNA directly, but rather mediate protein-protein interactions between regulatory transcription factors and the basal transcription machinery.

23 GO annotations of biological process

Name Definition
angiogenesis Blood vessel formation when new vessels emerge from the proliferation of pre-existing blood vessels.
blastocyst development The process whose specific outcome is the progression of the blastocyst over time, from its formation to the mature structure. The mammalian blastocyst is a hollow ball of cells containing two cell types, the inner cell mass and the trophectoderm.
cardiac left ventricle formation The developmental process pertaining to the initial formation of a left cardiac ventricle from unspecified parts.
cardiac right ventricle formation The developmental process pertaining to the initial formation of a right cardiac ventricle from unspecified parts.
cardiac septum morphogenesis The process in which the anatomical structure of a cardiac septum is generated and organized. A cardiac septum is a partition that separates parts of the heart.
cartilage morphogenesis The process in which the anatomical structures of cartilage are generated and organized.
developmental process A biological process whose specific outcome is the progression of an integrated living unit: an anatomical structure (which may be a subcellular structure, cell, tissue, or organ), or organism over time from an initial condition to a later condition.
embryonic heart tube development The process whose specific outcome is the progression of the embryonic heart tube over time, from its formation to the mature structure. The heart tube forms as the heart rudiment from the heart field.
embryonic heart tube formation The process that gives rise to the embryonic heart tube. This process pertains to the initial formation of a structure from unspecified parts. The embryonic heart tube is an epithelial tube that will give rise to the mature heart.
heart development The process whose specific outcome is the progression of the heart over time, from its formation to the mature structure. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood.
heart looping The tube morphogenesis process in which the primitive heart tube loops asymmetrically. This looping brings the primitive heart chambers into alignment preceding their future integration. Heart looping begins with dextral-looping and ends when the main regional divisions of the mature heart and primordium of the great arterial trunks become established preceeding septation.
mesenchyme development The process whose specific outcome is the progression of a mesenchymal tissue over time, from its formation to the mature structure. A mesenchymal tissue is made up of loosely packed stellate cells.
mesoderm formation The process that gives rise to the mesoderm. This process pertains to the initial formation of the structure from unspecified parts.
negative regulation of DNA-binding transcription factor activity Any process that stops, prevents, or reduces the frequency, rate or extent of the activity of a transcription factor, any factor involved in the initiation or regulation of transcription.
negative regulation of DNA-templated transcription Any process that stops, prevents, or reduces the frequency, rate or extent of cellular DNA-templated transcription.
negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding Any process that stops, prevents or reduces the frequency, rate or extent of RNA polymerase II regulatory region sequence-specific DNA binding.
negative regulation of transcription by RNA polymerase II Any process that stops, prevents, or reduces the frequency, rate or extent of transcription mediated by RNA polymerase II.
odontogenesis of dentin-containing tooth The process whose specific outcome is the progression of a dentin-containing tooth over time, from its formation to the mature structure. A dentin-containing tooth is a hard, bony organ borne on the jaw or other bone of a vertebrate, and is composed mainly of dentin, a dense calcified substance, covered by a layer of enamel.
positive regulation of transcription by RNA polymerase II Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
regulation of transcription by RNA polymerase II Any process that modulates the frequency, rate or extent of transcription mediated by RNA polymerase II.
trophectodermal cell differentiation The process in which a relatively unspecialized cell acquires the specialized features of a trophectoderm cell.
trophoblast giant cell differentiation The process in which a relatively unspecialized cell acquires specialized features of a trophoblast giant cell of the placenta. Trophoblast giant cells are the cell of the placenta that line the maternal decidua.
ventricular cardiac muscle tissue morphogenesis The process in which the anatomical structures of cardiac ventricle muscle is generated and organized.

5 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q0VCE2 HAND1 Heart- and neural crest derivatives-expressed protein 1 Bos taurus (Bovine) PR
Q90691 HAND1 Heart- and neural crest derivatives-expressed protein 1 Gallus gallus (Chicken) PR
Q9JLR5 Tcf23 Transcription factor 23 Mus musculus (Mouse) PR
Q64279 Hand1 Heart- and neural crest derivatives-expressed protein 1 Mus musculus (Mouse) PR
P97832 Hand1 Heart- and neural crest derivatives-expressed protein 1 Rattus norvegicus (Rat) PR
10 20 30 40 50 60
MNLVGSYAHH HHHHHPHPAH PMLHEPFLFG PASRCHQERP YFQSWLLSPA DAAPDFPAGG
70 80 90 100 110 120
PPPAAAAAAT AYGPDARPGQ SPGRLEALGG RLGRRKGSGP KKERRRTESI NSAFAELREC
130 140 150 160 170 180
IPNVPADTKL SKIKTLRLAT SYIAYLMDVL AKDAQSGDPE AFKAELKKAD GGRESKRKRE
190 200 210
LQQHEGFPPA LGPVEKRIKG RTGWPQQVWA LELNQ